EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion

Alexandra Irene Ziegler, Regina Heidenreich, Heidi Braumuller, Hartwig Wolburg, Susanne Weidemann, Ralph Mocikat, Martin Rocken

Research output: Contribution to journalArticleResearchpeer-review

67 Citations (Scopus)

Abstract

Experimental tumor vaccination and adop-tive T-cell therapies show that interferon-I? (IFN-I?)-producing CD4+ T helper cells (Th1) can be highly effective in tumor prevention and therapy.
Original languageEnglish
Pages (from-to)3494 - 3502
Number of pages9
JournalBlood
Volume113
Issue number15
DOIs
Publication statusPublished - 2009
Externally publishedYes

Cite this